09885

2.6302.05%
RS

Rong Shao

Independent Non-Executive Director

Dr. Rong Shao, Ph.D. is Independent director of Hainan Haiyao Co. Ltd. from July 23, 2025. Dr. Shao has been an Independent Director of I-Mab since June 1, 2021 until July, 2024. She had been Independent Non-Executive Director of Alibaba Health Information Technology Limited since August 11, 2023. She has extensive experience in the pharmaceutical industry. She holds various positions in China Pharmaceutical University of the People Republic of China (‘‘PRC’’), serving as the executive deputy director of its Research Center of National Drug Policy and Ecosystem and the executive dean of its Institute of Drug Regulatory Sciences, in charge of regulatory science disciplines and research. She is an Independent Non-Executive Director of YSB Inc. from June 28, 2023. She is a professor of drug administration policies and regulations, the Executive Deputy Director of the Research Center of National Drug Policy & Ecosystem (NDPE) and the Director of the NMPA Key Laboratory of Drug Regulatory Innovation and Evaluation, at China Pharmaceutical University. She is an Independent Director of Jiangsu gdk Biotechnology Co., Ltd. since June 15, 2020. She was also an Independent director of Changzhou Qianhong Biopharma Co., Ltd., from September 2014 to January 2021. She has been engaged in the research and education of drug policies and regulations for more than three decades and has contributed to the development of China's drug regulatory innovation and reform. She is a Board Member in academic associations, such as the China Pharmaceutical Association and the China Society for Drug Regulation. She is also an editorial Board Member of China Pharmacy, Chinese Journal of New Drugs and Chinese Journal of Health Policy. Dr. Shao obtained a Bachelor degree in Medicinal Chemistry in July 1983 from Nanjing College of Pharmacy (currently known as China Pharmaceutical University) in the PRC, a second Bachelor degree in Law in July 1989 from Nanjing University in the PRC and a PhD degree in Pharmacy Administration in July 2010 from Shenyang Pharmaceutical University in the PRC. She is a Chinese practicing lawyer.

Positions